Leon G. Cooperman's Schedule 13G Filing for DiaMedica Therapeutics Inc.

Leon G. Cooperman has filed a Schedule 13G with the SEC, disclosing beneficial ownership of 3,110,220 common shares of DiaMedica Therapeutics Inc., representing approximately 6.0% of the total outstanding shares. The shares are held directly by Mr. Cooperman and The Leon and Toby Cooperman Foundation. The filing indicates that the shares were not acquired for the purpose of influencing the control of the issuer. The filing is made under Rule 13d-1(c) and is signed by Edward Levy, Attorney-in-Fact for Mr. Cooperman.